GITELMAN SYNDROME PRESENTING AS HYPOKALEMIC PERIODIC PARALYSIS

Main Article Content

Dr. Vijaykumar Gulve
Dr. Vishal Balaso Shewale
Dr. Harsh Choudhari
Dr. Bhushan Labhade
Dr. Kranthi Koleti
Dr. Parth Maindarkar

Keywords

Gitelman Syndrome, Rennin angiotensin-aldosterone system, Tubulopathies, Sodium chloride co-transporter

Abstract

Gitelman syndrome (GS) is a very rare inherited disorder characterized by renal tubular dysfunction, primarily affecting the kidneys' ability to reabsorb electrolytes. There is a mutation in the gene SLC12A3 in the distal convoluted tubule of the nephron that causes this disease. Symptoms include weakness, fatigue, tingling, and muscle spasms. Diagnosis is often incidental during lab tests or when symptoms appear. Treatment focuses on correcting electrolyte imbalances with magnesium and potassium supplements, aldosterone antagonists like spironolactone, and NSAIDs for symptom management. In the presented case, a 26-year-old female was diagnosed with Gitelman syndrome after presenting with tingling and spasms. The treatment included spironolactone, vitamin D3, febuxostat, indomethacin, and a potassium supplement. Regular follow-up is essential to prevent further complications.

Abstract 44 | pdf Downloads 60

References

1. Gunde R, Jayashankar CA, Bhat N, Bhat V, Kodapala S. Gitelman Syndrome Manifesting with Acute Hypokalemic Paralysis: A Case Report. Cureus. 2023; 15(9).
2. Parmar MS, Muppidi V, Bashir K. Gitelman Syndrome. [Updated 2024 Apr 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459304/
3. Hiba S, Shazaan N, Abdullah FN, Mehdi KM, Rizvi SW. Gitelman Syndrome and Hypertension: A Case Report. Cureus. 2023; 15(9).
4. De Silva N, Pathmanathan S, Sumanatilleke M, et al. A novel mutation of SLC12A3 gene causing Gitelman syndrome. SAGE Open Med Case Rep. 2022; 10:2050313X221102294.
5. Nakhoul F, Nakhoul N, Dorman E, Berger L, Skorecki K, Magen D. Gitelman's syndrome: a pathophysiological and clinical update. Endocrine. 2012; 41(1):53-57.
6. Grillone T, Menniti M, Bombardiere F, et al. New SLC12A3 disease causative mutation of Gitelman's syndrome. World J Nephrol. 2016; 5(6):551-555.
7. National Organization for Rare Disorder. Gitelman Syndrome:https://rarediseases.org/rare-diseases/gitelman-syndrome/Last updated: 10/9/2024
8. Gandhi K, Prasad D, Malhotra V, Agrawal D. Gitelman's syndrome presenting with hypocalcemic tetany and hypokalemic periodic paralysis. Saudi J Kidney Dis Transpl. 2016;27(5):1026-1028.
9. Saiki S, Yoshioka A, Saiki M, Yamaya Y, Hirose G. Rinsho Shinkeigaku. 2002; 42(4):317-319.
10. Sinaga F, Naibah R, & Sibuea W. Gitelman Syndrome: An Important Cause of Severe Hypokalemia and Periodic Paralysis. World Journal of Nephrology and Urology, 2016; 5(2):40-47.
11. Balasubramani LN, Iyer S. Gitelman Syndrome: A Cause for Recurrent Hypokalaemia with Tetany. J Clin of Diagn Res.2020; 14(4):OD04-OD05.
12. Gulwe VS, Ukadgaonkar A, Bhutada SS, Dahiya N. Rare presentation of Gitelman’s syndrome. Int J Curr Med Appl Sci. 2015; 9(1):36-8.